Table 1.
Expression pattern of survivin, p53 and Bcl-2 in liver metastases pre- and post -90Y-RE
|
Biomarkers |
Number of patients (%) |
|
|---|---|---|
| Pre-90Y-RE (N = 29) | Post-90Y-RE (N = 15) | |
|
Survivin N (%) |
|
|
| Negative (≤ 20) |
5 (16.2) |
10 (66.7) |
| Positive (> 20) |
24 (77.4) |
5 (33.3) |
|
p53 N (%) |
|
|
| Negative (≤ 10) |
2 (6.9) |
4 (26.7) |
| Positive (> 10) |
27 (93.1) |
11 (73.3) |
|
Bcl-2 N (%) |
|
|
| Negative (≤ 5) |
18 (62.1) |
11 (73.3) |
| Positive (> 5) |
11 (37.9) |
4 (26.7) |
|
Ki-67 N (%) |
|
|
| Negative (<50) |
11 (37.5) |
9 (60.0) |
| Positive (≥ 50) | 18 (62.5) | 6 (40.0) |